YTEN stock: buy or sell?
January 24th, 2020
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States.
Should I buy YTEN stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Yield10 Bioscience stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Yield10 Bioscience stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 5 ratings published for YTEN stock in the last 30 days. The general sentiment of these ratings is bullish for YTEN stock, with 5 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
YTEN stock analysis
After sliding a hair-raising -9.76% on January 23rd, Yield10 Bioscience closed yesterday at $6.77 and boosted an outstanding 8.32%.
After sliding a hair-raising -9.76% on Jan 23rd, Yield10 Bioscience closed yesterday at $6.77 and boosted an outstanding 8.32%.
After sliding a frightening -29.41% in a week last week, Yield10 Bioscience closed this week at $6.77 and remained stable a lame -0.44%. Early January YTEN rocketed an outstanding 9.09% in just one week.
Since price and 40-weeks moving average lines crossed down early March, YTEN fell $-46.43 per share (-87.27%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average line is not recommended by many experts, as it indicates that the stock has not enough institutional support.
YTEN stock price history
YTEN stock went public on November 10th, 2006 with a price of $34,200.001. Since then, YTEN stock sliced a -100.00%, with a yearly average of -7.70%.
1: Adjusted price after possible price splits or reverse-splits.
YTEN stock historical price chart
YTEN stock reached 52-week highs on March at $70.80, and all-time highs 2007-04-27 with a price of 70488.
YTEN stock price target is $4.00Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we found 3 price predictions for YTEN stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-3-26||Maxim Group||Set Price Target||n/a||$5.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on March, Yield10 Bioscience . As soon as we get its actual EPS from the earnings report, we will update this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw a hair-raising drop down of -41.10% to $0.56 million dollars. When comparing 2018 vs 2017, similarly, profit margin (that is, the net income divided by revenues) plunged a -653.94% to -1,649.28%.
|2013||$5.39 M||-||$-30.51 M-566.0%||-|
|2014||$2.80 M||-48.05%||$-29.53 M-1054.8%||-3.20%|
|2015||$2.59 M||-7.36%||$-23.68 M-912.9%||-19.82%|
|2016||$1.16 M||-55.32%||$-7.60 M-656.1%||-67.89%|
|2017||$0.94 M||-18.55%||$-9.40 M-995.3%||23.57%|
|2018||$0.56 M||-41.10%||$-9.17 M-1649.3%||-2.41%|
Quarterly financial resultsYield10 Bioscience posted $0.14 million in revenues for 2018-Q4, a 77.63% up compared to previous quarter. Reported quarter income marked $-1.86 million with a profit margin of -1,377.78%. Profit margin rocketed a 2,082.75% compared to previous quarter when profit margin was -3,460.53%. When comparing sales to same quarter last year, Yield10 Bioscience sales marked an astounding gain and rocketed a 29.81%.
|2017-Q1||$0.32 M||-||$-2.09 M-645.1%||-|
|2017-Q2||$0.29 M||-9.57%||$-2.73 M-931.7%||30.62%|
|2017-Q3||$0.22 M||-23.89%||$-2.03 M-908.1%||-25.82%|
|2017-Q4||$0.10 M||-53.36%||$-2.55 M-2453.8%||26.02%|
|2018-Q1||$0.06 M||-42.31%||$-2.29 M-3816.7%||-10.27%|
|2018-Q2||$0.29 M||375.00%||$-2.39 M-838.6%||4.37%|
|2018-Q3||$0.08 M||-73.33%||$-2.63 M-3460.5%||10.04%|
|2018-Q4||$0.14 M||77.63%||$-1.86 M-1377.8%||-29.28%|
Yield10 Bioscience ownershipWhen you are planning to buy a stock, it's always worth to review its ownership structure.
Yield10 Bioscience shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 6.79% of all shares.
In case of Yield10 Bioscience stock, 19.05% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for YTEN stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Yield10 Bioscience:
|Market cap||$195.0 M|
|Total shares||28.8 M|
|Float shares||9.5 M|
|- Institutional holdings (%)||19.1%|
|- Insider holdings (%)||6.8%|
|Shares in short selling||0.0%|
|Friday, January 24th, 2020|
|Day range||$5.64 - $6.82|
|Average true range||$1.72|
|50d mov avg||$6.89|
|100d mov avg||$15.83|
|200d mov avg||$28.42|
Yield10 Bioscience performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Yield10 Bioscience against in the following table: